Literature DB >> 8902377

New imaging techniques for assessing cardiac function.

L L Johnson1, M A Lawson.   

Abstract

In summary, newer imaging technologies yield three-dimensional pictures of the left ventricle. Detailed information is provided on regional wall motion, wall thickening, and ventricular volumes, which can be helpful in managing patients with cardiac disease. MR imaging gives the highest resolution images, and MR angiography can be invaluable in assessing the anatomy of an aortic dissection. Gated tomography with a technetium-based myocardial perfusion tracer can be thought of as a low-resolution cine MR imaging study. Combined function and perfusion nuclear studies performed at rest in an ICU can give information on myocardial perfusion and stunning, which is helpful in managing patients with acute ischemic syndromes. First pass RNA is probably the most accurate method for measuring RVEF and can be performed at the bedside using a portable multicrystal camera. Serial measurements of RVEF may be helpful in managing patients with pulmonary hypertension of various causes. For patients with documented acute myocardial infarction or chest pain and no acute myocardial necrosis or for patients undergoing preoperative risk assessment, combined perfusion and function using nuclear techniques yields both stress-induced ischemia and resting ventricular function in a single procedure and is timely and cost effective.

Entities:  

Mesh:

Year:  1996        PMID: 8902377     DOI: 10.1016/s0749-0704(05)70285-2

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  1 in total

1.  Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome.

Authors:  Nili Zafrir; Boris Zingerman; Alejandro Solodky; Daniel Ben-Dayan; Alex Sagie; Jaqueline Sulkes; Israel Mats; M R Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.